PANI, FABIANA
 Distribuzione geografica
Continente #
EU - Europa 80.939
NA - Nord America 3.195
AS - Asia 1.352
SA - Sud America 186
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 30
OC - Oceania 3
Totale 85.872
Nazione #
IT - Italia 79.991
US - Stati Uniti d'America 3.110
SG - Singapore 503
CN - Cina 501
SE - Svezia 187
UA - Ucraina 167
BR - Brasile 146
FR - Francia 140
VN - Vietnam 123
DE - Germania 119
GB - Regno Unito 99
FI - Finlandia 77
NL - Olanda 47
CA - Canada 42
IN - India 40
HK - Hong Kong 29
MX - Messico 28
KR - Corea 26
PL - Polonia 18
TR - Turchia 18
BE - Belgio 15
RU - Federazione Russa 15
BD - Bangladesh 14
IQ - Iraq 14
IR - Iran 13
JP - Giappone 12
AR - Argentina 10
ZA - Sudafrica 10
ES - Italia 9
PK - Pakistan 8
EC - Ecuador 7
EU - Europa 7
PT - Portogallo 7
AL - Albania 6
CO - Colombia 6
ID - Indonesia 6
MA - Marocco 6
SA - Arabia Saudita 6
VE - Venezuela 6
AT - Austria 5
CH - Svizzera 5
IE - Irlanda 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IL - Israele 4
JO - Giordania 4
LT - Lituania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
HR - Croazia 3
JM - Giamaica 3
MY - Malesia 3
PS - Palestinian Territory 3
RO - Romania 3
UZ - Uzbekistan 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
AO - Angola 1
BH - Bahrain 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 85.712
Città #
Cagliari 74.800
Uta 1.118
Ashburn 368
Rome 320
Milan 319
Singapore 286
San Jose 199
Chandler 193
Woodbridge 172
Dallas 157
Fairfield 142
Nyköping 124
Houston 111
Dearborn 105
Beijing 101
Boardman 92
New York 85
Wilmington 85
Naples 78
Los Angeles 73
Ann Arbor 72
Seattle 70
Bologna 63
Helsinki 63
Shanghai 61
Cambridge 56
Florence 56
The Dalles 55
Santa Clara 53
Ho Chi Minh City 45
Palermo 44
Jacksonville 43
Lauterbourg 40
Boston 38
Council Bluffs 38
Nanjing 38
Turin 38
Bari 37
Catania 35
Munich 34
Genoa 28
Hong Kong 27
Hanoi 25
Seoul 25
Toronto 24
Atlanta 22
Buffalo 22
Padova 22
San Diego 21
Bergamo 19
Guangzhou 19
Parma 19
San Mateo 18
São Paulo 18
Torino 18
Chicago 17
London 17
Zhengzhou 17
Dong Ket 16
Monza 16
Avellino 15
Frankfurt am Main 15
Hebei 15
Orem 15
Pescara 15
Redwood City 15
Reggio Calabria 15
Shenyang 15
Tianjin 15
Jiaxing 14
Brescia 13
Modena 13
Mountain View 13
Nanchang 13
Montecchio Maggiore 12
Verona 12
Messina 11
Perugia 11
Phoenix 11
Salerno 11
Sassari 11
Tokyo 11
Baltimore 10
Foggia 10
Genova 10
Rimini 10
Varazze 10
Augusta 9
Basingstoke 9
Brussels 9
Changsha 9
Chennai 9
Como 9
Segrate 9
Brooklyn 8
Da Nang 8
Denver 8
Hefei 8
Leawood 8
Lissone 8
Totale 80.769
Nome #
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 5.017
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.893
Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells 3.435
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.313
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.186
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 3.134
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.997
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.996
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.983
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.968
Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells 2.819
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.736
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.665
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.648
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.509
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.488
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.476
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.415
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.355
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.349
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.263
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.253
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.240
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.154
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.129
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 2.063
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 2.030
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 2.004
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.969
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.968
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.356
Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma 1.283
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 818
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 792
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients. 168
Totale 85.872
Categoria #
all - tutte 102.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.339 0 0 0 458 349 338 287 239 444 437 390 397
2022/20236.015 560 912 896 460 414 375 306 419 424 369 574 306
2023/20246.317 405 242 260 391 568 958 981 569 306 402 624 611
2024/202510.171 2.590 2.943 1.199 1.020 559 620 717 74 136 113 108 92
2025/20262.976 222 110 241 159 263 219 430 423 213 396 159 141
2026/2027479 55 136 260 28 0 0 0 0 0 0 0 0
Totale 85.872